{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-26-002794","form_type":"8-K","ticker":"PMI","cik":"0002030617","company_name":"Picard Medical, Inc.","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.047063+00:00","generated_at":"2026-05-15T08:43:40.240534+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"medium","headline":"Picard Medical FY2025 revenue $4.94M (+12.5% YoY); U.S. rev +33.5%","bullets":["Revenue $4.94M (+12.5% YoY); U.S. revenue +33.5% to 88.25% of total.","Net loss ~$27M (incl. $14.5M non-cash); cash burn $15.67M; IPO raised $35.55M.","Emperor TAH in preclinical; FDA Breakthrough designation possible in 2026; 2028 clinical study target.","Manufacturing: valve assembly in-house, driver transfer to China, second source qualification."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-002794","json":"https://secwatch.observer/filing/0001829126-26-002794.json","markdown":"https://secwatch.observer/filing/0001829126-26-002794.md","text":"https://secwatch.observer/filing/0001829126-26-002794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626002794/0001829126-26-002794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626002794/picardmedical_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:43:40.240534+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}